𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients

✍ Scribed by Valerio Giannelli; Michela Giusto; Alessio Farcomeni; Francesca R. Ponziani; Maurizio Pompili; Raffaella Viganò; Rosa Maria Iemmolo; Maria F. Donato; Maria Rendina; Pierluigi Toniutto; Luisa Pasulo; Maria Cristina Morelli; Eleonora De Martin; Lucia Miglioresi; Daniele Di Paolo; Stefano Fagiuoli; Manuela Merli; AISF RECOLT-C group study

Book ID
115134847
Publisher
Springer
Year
2012
Tongue
English
Weight
71 KB
Volume
25
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of hepatitis C in liver transp
Treatment of hepatitis C in liver transplant recipients
✍ Fredric D. Gordon; Paul Kwo; Hugo E. Vargas 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

Recurrent hepatitis C after liver transplantation is a universal phenomenon. Graft reinfection occurs rapidly; once it is established, allograft cirrhosis and decompensation rapidly ensue in many patients. Treatment with pegylated interferon plus ribavirin is the standard of care among nontransplant

Anemia in liver transplant recipients un
Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C
✍ Sammy Saab; Mina K. Oh; Ayman B. Ibrahim; Francisco Durazo; Steven Han; Hasan Ye 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

Adherence to antiviral therapy is essential to achieve sustained virological responses in patients treated for hepatitis C. An important limitation to use of appropriate doses of ribavirin is development of anemia. The aim of this study is to identify risk factors associated with anemia in liver tra